Sreeneeranj Kasichayanula, PhD (he/him/his)

Executive Director, Clinical Pharmacology
Gilead Sciences

Sree Kasichayanula, PhD, is a Executive Director and therapeutic head for Immuno-Oncology Clinical Pharmacology at Gilead Sciences. He has previously worked in leadership positions in the field of Cancer Immunotherapy at AbbVie, Amgen and at BMS. Sree has published extensively in the field of Clinical Pharmacology and Cancer Immunotherapy. He has been an active member of ASCPT since 2008 and has served on several committees within ASCPT and ACCP organizations.

Disclosure(s): Gilead Sciences: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Presentation(s):

• Clinical Trial Diversity & Inclusion: How Clinical Pharmacology Can Support the Implementation of Regulatory Guidance on Diversity Plans

  Tuesday, March 26, 2024
  8:30 AM – 5:30 PM MDT